The workplace project – putting learning into practice

Taking practical education to a fundamental level, every two-module MasterClass includes an intermodule project as a mandatory part of the course. An opportunity to test new knowledge and skills and to improve local services, delegates are offered mentorship and encouraged to support their peers as they continue to develop their specialism in a way that directly impacts their patient's outcomes.

Attendees have free reign over this project. It might be service delivery, patient management or drug treatments, and it could take the form of a service description, an audit, or another form of research. It should meet a local need.

When complete, the project closes with a presentation to the other course members, faculty, and often their managers, commissioners or other people of influence in their area. The group chooses a winner and runner up who receive an award at an evening event.


Spotlight Projects


Multiple Sclerosis relapses: improving patient education
By Nicole Japzon, Neurology Physician Associate Band 7, University College London Hospitals NHS Foundation Trust & Flordeliza Madriaga, MS Clinical Nurse Specialist, University College London Hospitals NHS Foundation Trust
Patient engagement to inform changes in Multiple Sclerosis (MS) services in City and Hackney August 2022
By Sarah German, MS Specialist Practitioner Band 7, Homerton University Hospital NHS Foundation Trust
Reducing Delays to DMT Initiation via Homecare Prescriptions in Multiple Sclerosis
By Rebecca Harrison, Specialist Pharmacist for Neurology & Stroke Band 8, Royal United Hospitals Bath NHS Foundation Trust
Setting Up A Pathway to Improve Management of Cognitive Impairment in People With MS Using Screening With The Symbol Digit Modality Test Prior To Referral To Neuropsychology
By Ruth Stross, MS Nurse Specialist, Epsom and St Helier University Hospitals NHS Trust & Dr Victoria Wallace, Neurologist ST6, St George's University Hospitals NHS Foundation Trust

All projects


Showing 37-45 of 54 projects

Early monitoring of B cells on Ocrelizumab may help to identify those at risk of adverse effects
By Chandni Radia, Lead Pharmacist Neurosciences, Imperial College Healthcare NHS Trust
Time from ‘treatment decision’ to ‘actual start of DMT’ in MS – a local clinical survey
By Dr Bindu Yoga, Consultant Neurologist, Mid Yorkshire Hospitals NHS Trust
Audit of safe monitoring of MS patients on natalizumab
By Dr Lewis Kass-lliyya, Dr Jennifer Hosty and Dr Simon Bell, Royal Hallamshire Hospital (Supervisor: Dr David Paling)
Fingolimod safety considerations in real-world practice: fingolimod-associated macular oedema (FAME)
By Dr Paul Gallagher and Dr Sarah-Jane Martin, Institute of Neurological Sciences, Glasgow
Listeriosis prevention in alemtuzumab treated patients
By Dr Rachelle Shafei, Clinical Research Fellow, University College London